{
    "title": "Pfizer/BioNTech say booster dose increases protection vs Omicron in kids aged 5-11",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10719677/Pfizer-BioNTech-say-booster-dose-increases-protection-vs-Omicron-kids-aged-5-11.html",
    "date": "2022-04-14",
    "keywords": [
        "dose",
        "vaccine",
        "booster",
        "age",
        "group",
        "study",
        "hospitalization",
        "roy",
        "protection",
        "agency",
        "health",
        "data",
        "need",
        "illness",
        "infection",
        "hadland",
        "covid19",
        "pfizer",
        "inc",
        "biontech",
        "omicron",
        "variant",
        "coronavirus",
        "blood",
        "serum",
        "analysis",
        "increase",
        "neutralizing",
        "version",
        "virus",
        "emergency",
        "use",
        "authorization",
        "mid",
        "safety",
        "immunogenicity",
        "demand",
        "disease",
        "control",
        "prevention",
        "promising",
        "size",
        "extent",
        "number",
        "response",
        "future",
        "bershteyn",
        "langone",
        "scepticism",
        "risk",
        "chief",
        "medicine",
        "mass",
        "hospital",
        "pandemic",
        "year",
        "food",
        "drug",
        "administration",
        "time",
        "bengaluru",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}